Episode #2
When a biotech story has to travel without its founder (ProTGen)
<p>What happens when a breakthrough biotech company outgrows its founder’s ability to personally tell the story?</p><p>In this episode, we explore a challenge facing many science-led startups: the transition from a founder-carried narrative to a market-carried narrative. Using ProTGen as a case study, we unpack why the next stage of growth requires more than a polished pitch deck, refreshed website, or redesigned one-pager. It requires what we call portable conviction. </p><p>We discuss:</p>Why great science often suffers from having too many compelling storiesThe difference between explaining a company and creating belief in a com...

